ArticleRadiology case reports2026
A case of adenoid cystic carcinoma of the larynx: Diagnostic challenges, surgical management, and long-term surveillance.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenoid cystic carcinoma of the larynx is an uncommon malignant neoplasm, accounting for less than 1% of all laryngeal cancers. It arises from minor salivary glands, predominantly located in the subglottic region. ACC is characterized by slow but aggressive growth, with a notable propensity for perineural invasion and distant hematogenous dissemination, particularly to the lungs, which occurs in approximately 35%-50% of cases. Clinical presentation depends on tumor localization and may include dyspnea, dysphonia, dysphagia, and otalgia. Diagnosis is based on clinical and endoscopic examination, supplemented by imaging modalities such as MRI and CT scans, and confirmed by histopathological evaluation, which typically reveals a cribriform growth pattern. Immunohistochemical analysis frequently shows strong positivity for c-kit (CD117) and CK7, with negative expression for thyroid-specific markers (TTF-1, thyroglobulin), excluding a thyroid origin. The standard therapeutic approach involves wide surgical excision, most often via total laryngectomy, with selective neck dissection performed in cases with clinical or radiological evidence of lymph node involvement, although nodal metastases remain uncommon. Postoperative radiotherapy is generally indicated due to the tumor's relative radioresistance and its tendency for perineural spread. Chemotherapy plays a limited role, reserved for advanced or metastatic disease. Given the high risk of late recurrences and distant metastases, long-term follow-up is essential, despite a reported 5-year overall survival rate of approximately 70%. We report the case of a 58-year-old female patient with no history of tobacco or alcohol use, but with a 25-year occupational exposure to irritant vapors in the chemical industry. She presented with progressively worsening dysphonia over approximately 10 months, followed by the onset of laryngeal dyspnea. A comprehensive clinical evaluation, supported by laboratory testing and imaging studies, led to the diagnosis of adenoid cystic carcinoma of the larynx. This exceedingly rare tumor may present with nonspecific symptoms and mimic other head and neck disorders, particularly thyroid-related pathologies. Therefore, a high index of clinical suspicion is essential to avoid diagnostic delays. Early diagnosis and prompt management are critical, and treatment should be based on a multidisciplinary and individualized approach to optimize oncological outcomes while preserving laryngeal function and the patient's quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.